Skip to main content
Erschienen in: World Journal of Surgery 3/2021

11.11.2020 | Original Scientific Report

Impacts of Preoperative Psoas Muscle Mass and Visceral Fat Area on Postoperative Short- and Long-Term Outcomes in Patients with Gastric Cancer

verfasst von: Yoshiki Taniguchi, Yukinori Kurokawa, Tsuyoshi Takahashi, Takuro Saito, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Makoto Yamasaki, Kiyokazu Nakajima, Hidetoshi Eguchi, Yuichiro Doki

Erschienen in: World Journal of Surgery | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Sarcopenia and obesity are associated with outcomes after surgery. However, few studies have investigated which more accurately predicts postoperative complications or prognosis in patients with gastric cancer.

Methods

A total of 567 consecutive patients with gastric cancer who underwent gastrectomy between 2010 and 2015 were retrospectively reviewed. Psoas muscle mass index (PMI) and visceral fat area (VFA) were measured by CT scan. Patients were divided into two groups based on PMI (PMI-H group: male ≥ 6.36 cm2/m2, female ≥ 3.92 cm2/m2; and PMI-L group: male < 6.36 cm2/m2, female < 3.92 cm2/m2) and two groups based on VFA (VFA-H group: ≥ 100 cm2; VFA-L group: < 100 cm2). The incidence of postoperative complications and the recurrence-free survival (RFS) were compared between the two groups.

Results

The incidence of postoperative complications was significantly higher in the VFA-H group than in the VFA-L group (35.1% vs. 20.3%; P < 0.001), whereas there was no significant difference between the PMI-H and PMI-L groups. Multivariate analysis showed that PMI-L and VFA-H were independent risk factors for pneumonia (odds ratio, 4.49; P = 0.018) and intra-abdominal abscess (odds ratio, 5.19; P = 0.004), respectively. While there was no significant difference in RFS between the VFA-H and VFA-L groups, the PMI-L group showed significantly worse RFS than the PMI-H group (P < 0.001).

Conclusions

PMI and VFA were useful predictive factors for postoperative pneumonia and intra-abdominal abscess, respectively. PMI might be a useful prognostic factor in patients with gastric cancer, but VFA is not.
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRef Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRef
2.
Zurück zum Zitat Hashimoto T, Kurokawa Y, Mori M et al (2018) Update on the treatment of gastric cancer. JMA J 1:40–49CrossRef Hashimoto T, Kurokawa Y, Mori M et al (2018) Update on the treatment of gastric cancer. JMA J 1:40–49CrossRef
3.
Zurück zum Zitat Kurokawa Y, Doki Y, Mizusawa J et al (2018) Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol 3:460–468CrossRef Kurokawa Y, Doki Y, Mizusawa J et al (2018) Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol 3:460–468CrossRef
4.
Zurück zum Zitat Papenfuss WA, Kukar M, Oxenberg J et al (2014) Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol 9:3008–3014CrossRef Papenfuss WA, Kukar M, Oxenberg J et al (2014) Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol 9:3008–3014CrossRef
5.
Zurück zum Zitat Hartgrink HH, Jansen EP, van Grieken NC et al (2009) Gastric cancer. Lancet 9688:477–490CrossRef Hartgrink HH, Jansen EP, van Grieken NC et al (2009) Gastric cancer. Lancet 9688:477–490CrossRef
6.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on Sarcopenia in older people. Age Ageing 39(4):412–423CrossRef Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on Sarcopenia in older people. Age Ageing 39(4):412–423CrossRef
7.
Zurück zum Zitat Womer AL, Brady JT, Kalisz K et al (2018) Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection? Am J Surg 215(3):503–506CrossRef Womer AL, Brady JT, Kalisz K et al (2018) Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection? Am J Surg 215(3):503–506CrossRef
8.
Zurück zum Zitat Park SY, Yoon JK, Lee SJ et al (2017) Prognostic value of preoperative total psoas muscle area on long-term outcome in surgically treated oesophageal cancer patients. Interact Cardiovasc Thorac Surg 24(1):13–19CrossRef Park SY, Yoon JK, Lee SJ et al (2017) Prognostic value of preoperative total psoas muscle area on long-term outcome in surgically treated oesophageal cancer patients. Interact Cardiovasc Thorac Surg 24(1):13–19CrossRef
9.
Zurück zum Zitat Kang J, Baek SE, Kim T et al (2012) Impact of fat obesity on laparoscopic total mesorectal excision: more reliable indicator than body mass index. Int J Colorectal Dis 27:497–505CrossRef Kang J, Baek SE, Kim T et al (2012) Impact of fat obesity on laparoscopic total mesorectal excision: more reliable indicator than body mass index. Int J Colorectal Dis 27:497–505CrossRef
10.
Zurück zum Zitat Kuritzkes BA, Pappou EP, Kiran RP et al (2018) Visceral fat area, not body mass index, predicts postoperative 30-days morbidity in patients undergoing colon resection for cancer. Int J Colorectal Dis 33(8):1019–1028CrossRef Kuritzkes BA, Pappou EP, Kiran RP et al (2018) Visceral fat area, not body mass index, predicts postoperative 30-days morbidity in patients undergoing colon resection for cancer. Int J Colorectal Dis 33(8):1019–1028CrossRef
11.
Zurück zum Zitat Japanese Gastric Cancer Association (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20:1–19CrossRef Japanese Gastric Cancer Association (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20:1–19CrossRef
12.
Zurück zum Zitat Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nippon Geka Gakkai Zasshi 85:1001–1005 (in Japanese)PubMed Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nippon Geka Gakkai Zasshi 85:1001–1005 (in Japanese)PubMed
13.
Zurück zum Zitat Saito T, Kurokawa Y, Miyazaki Y et al (2015) Which is a more reliable indicator of survival after gastric cancer surgery: Postoperative complication occurrence or C-reactive protein elevation? J Surg Oncol 112:894–899CrossRef Saito T, Kurokawa Y, Miyazaki Y et al (2015) Which is a more reliable indicator of survival after gastric cancer surgery: Postoperative complication occurrence or C-reactive protein elevation? J Surg Oncol 112:894–899CrossRef
14.
Zurück zum Zitat Kurokawa Y, Yamashita K, Kawabata R et al (2020) Prognostic value of postoperative C-reactive protein elevation versus complication occurrence: a multicenter validation study. Gastric Cancer 23(5):937–943CrossRef Kurokawa Y, Yamashita K, Kawabata R et al (2020) Prognostic value of postoperative C-reactive protein elevation versus complication occurrence: a multicenter validation study. Gastric Cancer 23(5):937–943CrossRef
15.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRef
16.
Zurück zum Zitat Katayama H, Kurokawa Y, Nakamura K et al (2015) Extended clavien-dindo classification of surgical complications: Japan clinical oncology group postoperative complications criteria. Surg Today 46:668–685CrossRef Katayama H, Kurokawa Y, Nakamura K et al (2015) Extended clavien-dindo classification of surgical complications: Japan clinical oncology group postoperative complications criteria. Surg Today 46:668–685CrossRef
17.
Zurück zum Zitat Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112CrossRef Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112CrossRef
18.
Zurück zum Zitat Nishikawa H, Shiraki M, Hiramatsu A et al (2016) Japan society of hepatology guidelines for sarcopenia in liver disease (1st Edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res 46:951–963CrossRef Nishikawa H, Shiraki M, Hiramatsu A et al (2016) Japan society of hepatology guidelines for sarcopenia in liver disease (1st Edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res 46:951–963CrossRef
19.
Zurück zum Zitat Examination Committee of Criteria for “Obesity Disease” in Japan; Japan Society for the Study of Obesity (2002) New criteria for “obesity disease” in Japan. Circ J 66:987–992CrossRef Examination Committee of Criteria for “Obesity Disease” in Japan; Japan Society for the Study of Obesity (2002) New criteria for “obesity disease” in Japan. Circ J 66:987–992CrossRef
20.
Zurück zum Zitat Hamaguchi Y, Kaido T, Okumura S et al (2016) Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition 32:1200–1205CrossRef Hamaguchi Y, Kaido T, Okumura S et al (2016) Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition 32:1200–1205CrossRef
21.
Zurück zum Zitat Wakabayashi H, Matsushima M, Uwano R et al (2015) Skeletal muscle mass is associated with severe dysphagia in cancer patients. J Cachexia Sarcopenia Muscle 6(4):351–357CrossRef Wakabayashi H, Matsushima M, Uwano R et al (2015) Skeletal muscle mass is associated with severe dysphagia in cancer patients. J Cachexia Sarcopenia Muscle 6(4):351–357CrossRef
22.
Zurück zum Zitat Saitoh M, Ishida J, Konishi M et al (2016) The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: skeletal muscle mass is associated with severe dysphagia in cancer patients. J Cachexia Sarcopenia Muscle 7(2):233–234CrossRef Saitoh M, Ishida J, Konishi M et al (2016) The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: skeletal muscle mass is associated with severe dysphagia in cancer patients. J Cachexia Sarcopenia Muscle 7(2):233–234CrossRef
23.
Zurück zum Zitat Fukuda Y, Yamamoto K, Hirao M et al (2016) Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer 19(3):986–993CrossRef Fukuda Y, Yamamoto K, Hirao M et al (2016) Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer 19(3):986–993CrossRef
24.
Zurück zum Zitat Huang DD, Zhou CJ, Wang SL et al (2017) Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer. Surgery 161(3):680–693CrossRef Huang DD, Zhou CJ, Wang SL et al (2017) Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer. Surgery 161(3):680–693CrossRef
25.
Zurück zum Zitat Zhou CJ, Zhang FM, Zhang FY et al (2017) Sarcopenia: a new predictor of postoperative complications for elderly gastric cancer patients who underwent radical gastrectomy. J Surg Res 211:137–146CrossRef Zhou CJ, Zhang FM, Zhang FY et al (2017) Sarcopenia: a new predictor of postoperative complications for elderly gastric cancer patients who underwent radical gastrectomy. J Surg Res 211:137–146CrossRef
26.
Zurück zum Zitat Takeuchi M, Ishii K, Seki H et al (2016) Excessive visceral fat area as a risk factor for early postoperative complications of total gastrectomy for gastric cancer: a retrospective cohort study. BMC Surg 16(1):54CrossRef Takeuchi M, Ishii K, Seki H et al (2016) Excessive visceral fat area as a risk factor for early postoperative complications of total gastrectomy for gastric cancer: a retrospective cohort study. BMC Surg 16(1):54CrossRef
27.
Zurück zum Zitat Yoshikawa K, Shimada M, Kurita N et al (2011) Visceral fat area is superior to body mass index as a predictive factor for risk with laparoscopy-assisted gastrectomy for gastric cancer. Surg Endosc 25(12):3825–3830CrossRef Yoshikawa K, Shimada M, Kurita N et al (2011) Visceral fat area is superior to body mass index as a predictive factor for risk with laparoscopy-assisted gastrectomy for gastric cancer. Surg Endosc 25(12):3825–3830CrossRef
28.
Zurück zum Zitat Wang SL, Ma LL, Chen XY et al (2018) Impact of visceral fat on surgical complications and long-term survival of patients with gastric cancer after radical gastrectomy. Eur J Clin Nutr 72(3):436–445CrossRef Wang SL, Ma LL, Chen XY et al (2018) Impact of visceral fat on surgical complications and long-term survival of patients with gastric cancer after radical gastrectomy. Eur J Clin Nutr 72(3):436–445CrossRef
29.
Zurück zum Zitat Masamoto Y, Arai S, Sato T et al (2016) Adiponectin enhances antibacterial activity of hematopoietic cells by suppressing bone marrow inflammation. Immunity 44(6):1422–1433CrossRef Masamoto Y, Arai S, Sato T et al (2016) Adiponectin enhances antibacterial activity of hematopoietic cells by suppressing bone marrow inflammation. Immunity 44(6):1422–1433CrossRef
30.
Zurück zum Zitat Zhuang CL, Huang DD, Pang WY et al (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine 95(13):e3164CrossRef Zhuang CL, Huang DD, Pang WY et al (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine 95(13):e3164CrossRef
31.
Zurück zum Zitat Tamandl D, Paireder M, Asari R et al (2016) Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26(5):1359–1367CrossRef Tamandl D, Paireder M, Asari R et al (2016) Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26(5):1359–1367CrossRef
32.
Zurück zum Zitat Zheng ZF, Lu J, Zheng CH et al (2017) A novel prognostic scoring system based on preoperative sarcopenia predicts the long-term outcome for patients after R0 resection for gastric cancer: experiences of a high-volume center. Ann Surg Oncol 24(7):1795–1803CrossRef Zheng ZF, Lu J, Zheng CH et al (2017) A novel prognostic scoring system based on preoperative sarcopenia predicts the long-term outcome for patients after R0 resection for gastric cancer: experiences of a high-volume center. Ann Surg Oncol 24(7):1795–1803CrossRef
33.
Zurück zum Zitat Dodson S, Baracos VE, Jatoi A et al (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 62:265–279CrossRef Dodson S, Baracos VE, Jatoi A et al (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 62:265–279CrossRef
34.
Zurück zum Zitat Aoi W, Naito Y, Takagi T et al (2013) A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 62(6):882–889CrossRef Aoi W, Naito Y, Takagi T et al (2013) A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 62(6):882–889CrossRef
36.
Zurück zum Zitat Okumura S, Kaido T, Hamaguchi Y et al (2015) Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 157:1088–1098CrossRef Okumura S, Kaido T, Hamaguchi Y et al (2015) Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 157:1088–1098CrossRef
37.
Zurück zum Zitat Okumura S, Kaido T, Hamaguchi Y et al (2016) Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery 159:821–833CrossRef Okumura S, Kaido T, Hamaguchi Y et al (2016) Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery 159:821–833CrossRef
Metadaten
Titel
Impacts of Preoperative Psoas Muscle Mass and Visceral Fat Area on Postoperative Short- and Long-Term Outcomes in Patients with Gastric Cancer
verfasst von
Yoshiki Taniguchi
Yukinori Kurokawa
Tsuyoshi Takahashi
Takuro Saito
Kotaro Yamashita
Koji Tanaka
Tomoki Makino
Makoto Yamasaki
Kiyokazu Nakajima
Hidetoshi Eguchi
Yuichiro Doki
Publikationsdatum
11.11.2020
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 3/2021
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05857-9

Weitere Artikel der Ausgabe 3/2021

World Journal of Surgery 3/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.